12:00 AM
Aug 28, 2000
 |  BC Week In Review  |  Company News  |  Deals

Cubist, Xenogen deal

CBST obtained a license to evaluate Xenogen's real-time in vivo imaging technology that assesses new...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >